NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
This Quarter Return
-4.07%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$996M
AUM Growth
+$996M
(-2.4%)
Cap. Flow
+$58.7M
Cap. Flow
% of AUM
5.9%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
137
New
19
Increased
25
Reduced
38
Closed
13
Top Buys
| 1 |
Soleno Therapeutics
SLNO
|
$27.4M |
| 2 |
Establishment Labs
ESTA
|
$24.9M |
| 3 |
Peloton Interactive
PTON
|
$15.6M |
| 4 |
Savara
SVRA
|
$13.9M |
| 5 |
The Bancorp
TBBK
|
$12.8M |
Top Sells
| 1 |
Pathward Financial
CASH
|
$27.2M |
| 2 |
Lyra Therapeutics
LYRA
|
$17.5M |
| 3 |
Red Violet
RDVT
|
$16.9M |
| 4 |
Dyne Therapeutics
DYN
|
$12.4M |
| 5 |
Golden Entertainment
GDEN
|
$9.92M |
Sector Composition
| 1 | Healthcare | 68.09% |
| 2 | Consumer Discretionary | 12.03% |
| 3 | Financials | 6.24% |
| 4 | Communication Services | 6.07% |
| 5 | Technology | 3.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Milestone Pharmaceuticals
MIST
$156M
| $2.31M | 0.14% | 1,750,000 | – | – |
|
77
Xtant Medical Holdings
XTNT
$83.3M
| $2.26M | 0.13% | 3,580,000 -420,000 | -11% | -$265K |
|
|
CONN
78
DELISTED
Conn's Inc.
CONN
| $2.18M | 0.13% | 1,973,315 +203,318 | +11% | +$225K |
|
79
SPDR S&P Biotech ETF
XBI
$5.07B
| $2.07M | 0.12% | 22,369 -19,700 | -47% | -$1.83M |
|
80
Surrozen
SRZN
$104M
| $2.05M | 0.12% | +187,206 | New | +$2.05M |
|
81
Talphera
TLPH
$11.1M
| $1.77M | 0.1% | 1,992,519 | – | – |
|
82
Scully Royalty
SRL
$78.2M
| $1.7M | 0.1% | 239,197 | – | – |
|
83
MediaAlpha
MAX
$596M
| $1.63M | 0.1% | 123,564 -25,807 | -17% | -$340K |
|
84
SPAR Group
SGRP
$28.2M
| $1.6M | 0.09% | 662,028 -217,161 | -25% | -$523K |
|
85
Eledon Pharmaceuticals
ELDN
$155M
| $1.58M | 0.09% | +600,000 | New | +$1.58M |
|
86
Altisource Portfolio Solutions
ASPS
$126M
| $1.54M | 0.09% | 1,091,009 | – | – |
|
87
Unicycive Therapeutics
UNCY
$74M
| $1.41M | 0.08% | 2,820,358 -515,228 | -15% | -$258K |
|
88
Anebulo Pharmaceuticals
ANEB
$103M
| $1.4M | 0.08% | 511,073 | – | – |
|
89
Instil Bio
TIL
$182M
| $1.31M | 0.08% | 127,292 | – | – |
|
|
RNTX
90
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $1.29M | 0.08% | 464,367 +209,367 | +82% | +$580K |
|
91
Lazydays
GORV
$11M
| $1.27M | 0.07% | +500,000 | New | +$1.27M |
|
92
Verastem
VSTM
$569M
| $1.19M | 0.07% | +400,000 | New | +$1.19M |
|
93
Strata Skin Sciences
SSKN
$9.93M
| $933K | 0.05% | 303,917 -2,785,904 | -90% | -$8.55M |
|
94
Kiora Pharmaceuticals
KPRX
$9.55M
| $887K | 0.05% | 211,110 -1,688,890 | -89% | -$7.09M |
|
95
Perfect Corp
PERF
$209M
| $847K | 0.05% | 419,133 +219,133 | +110% | +$443K |
|
|
OKUR
96
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
$37.2M
| $846K | 0.05% | +547,804 | New | +$846K |
|
97
Aprea Therapeutics
APRE
$9.12M
| $837K | 0.05% | 205,760 | – | – |
|
|
NKLA
98
DELISTED
Nikola Corporation Common Stock
NKLA
| $819K | 0.05% | +99,999 | New | +$819K |
|
99
NeuroOne Medical Technologies
NMTC
$38.2M
| $761K | 0.04% | 950,962 -247,950 | -21% | -$198K |
|
|
IMTXW
100
DELISTED
Immatics N.V. Warrants
IMTXW
| $688K | 0.04% | 248,506 -310,471 | -56% | -$860K |
|